TGNA
50
3
PPL
62
2
REGN
62
3
RRC
62
-6
MCK
64
-2
AN
57
2
CCI
33
3
DD
67
15
SWN
60
-6
HON
55
2
PX
19
3
PEP
48
-2
SEE
48
4
TDC
70
3
RSG
67
-6
UA
29
-4
R
65
2
CCL
33
-6
HUM
36
2
DFS
56
-6
TGNA
50
3
PPL
62
2
REGN
62
3
RRC
62
-6
MCK
64
-2
AN
57
2
CCI
33
3
DD
67
15
SWN
60
-6
HON
55
2
PX
19
3
PEP
48
-2
SEE
48
4
TDC
70
3
RSG
67
-6
UA
29
-4
R
65
2
CCL
33
-6
HUM
36
2
DFS
56
-6
Financhill
Back

BridgeBio Pharma Stock Predictions

My #1 Coin is...

All the details are on the next page.
Sell
46

BBIO
BridgeBio Pharma

Last Price:
27.03
Seasonality Move:
32.95%

7 Day Trial

ALL ACCESS PASS

$ 7

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 36.7% based on the past 4 years of stock performance.
  • BridgeBio Pharma has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $27.02. The Score for BBIO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 36.7% based on the past 4 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
46
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • The current trend is relatively stagnant and BBIO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
44.32
52-Week Low:
12.75

Prediction Charts

Market Cap:
4.75B
Price in USD:
27.02
Volume:
1.97M
Beta:
1.07

Technical Analysis

SMA50:
28.90
SMA100:
32.94
SMA200:
30.91
52-Wk Change:
88.42%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 27.02 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-12 27.92 26.83 28.13 26.37
Apr-15 26.68 25.78 26.70 25.70
Apr-16 25.39 25.24 25.91 25.20
Apr-17 25.54 24.98 25.66 24.80
Apr-18 24.85 24.98 25.52 24.77
Apr-19 24.88 24.75 25.36 24.27
Apr-22 24.99 25.09 25.52 24.14
Apr-23 25.08 25.43 26.26 25.08
Apr-24 25.37 25.03 25.78 24.44
Apr-25 24.42 24.33 24.51 23.68
Apr-26 24.48 24.88 24.99 24.32
Apr-29 25.12 25.47 25.64 25.01
Apr-30 25.22 25.61 26.05 24.95
May-1 25.85 27.02 28.20 25.83

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.16 per share, an increase this year of $0.46 per share, and an increase next year of $0.54 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.